scholarly journals Value of Telemonitoring and Telemedicine in Heart Failure Management

2017 ◽  
Vol 3 (2) ◽  
pp. 1 ◽  
Author(s):  
Gian Franco Gensini ◽  
Camilla Alderighi ◽  
Raffaele Rasoini ◽  
Marco Mazzanti ◽  
Giancarlo Casolo ◽  
...  

The use of telemonitoring and telemedicine is a relatively new but quickly developing area in medicine. As new digital tools and applications are being created and used to manage medical conditions such as heart failure, many implications require close consideration and further study, including the effectiveness and safety of these telemonitoring tools in diagnosing, treating and managing heart failure compared to traditional face-to-face doctor–patient interaction. When compared to multidisciplinary intervention programs which are frequently hindered by economic, geographic and bureaucratic barriers, non-invasive remote monitoring could be a solution to support and promote the care of patients over time. Therefore it is crucial to identify the most relevant biological parameters to monitor, which heart failure sub-populations may gain real benefits from telehealth interventions and in which specific healthcare subsets these interventions should be implemented in order to maximise value.


2019 ◽  
Author(s):  
Peter Bogyi ◽  
Mate Vamos ◽  
Zsolt Bari ◽  
Balazs Polgar ◽  
Balazs Muk ◽  
...  

BACKGROUND Remote monitoring is an established, guideline-recommended technology with unequivocal clinical benefits; however, its ability to improve survival is contradictory. OBJECTIVE The aim of our study was to investigate the effects of remote monitoring on mortality in an optimally treated heart failure patient population undergoing CRT-D implantation in a large-volume tertiary referral centre. METHODS The population of this single-centre, retrospective, observational study included 231 consecutive patients receiving CRT-D devices in the Medical Centre of the Hungarian Defence Forces (Budapest, Hungary) from January 2011 to June 2016. Clinical outcomes were compared between patients on remote monitoring and on conventional follow-up. RESULTS The average follow-up time was 28.4 ± 18.1 months. Patients on remote monitoring suffered more likely from atrial fibrillation, received heart failure management at our dedicated heart failure outpatient clinic more often, and had a slightly lower NYHA functional class. Crude all-cause mortality of remote-monitored patients was significantly lower compared to patients followed conventionally (HR: 0.368, 95% CI: 0.186-0.727, p=0.004). The survival benefit remained statistically significant after adjustment for important baseline parameters (adjusted HR: 0.361, 95% CI: 0.181-0.722, p=0.004) CONCLUSIONS In this current single-centre, retrospective study of optimally treated heart failure patients undergoing CRT-D implantation, the use of remote monitoring systems was associated with significantly better survival.



2015 ◽  
Vol 21 (8) ◽  
pp. S44
Author(s):  
Lyle Olson ◽  
Virend Somers ◽  
Nancy Lexvold ◽  
Paul Friedman ◽  
Louis Schenck ◽  
...  


Sensors ◽  
2021 ◽  
Vol 21 (3) ◽  
pp. 887
Author(s):  
Jesse F. Veenis ◽  
Sumant P. Radhoe ◽  
Petra Hooijmans ◽  
Jasper J. Brugts

Heart failure (HF) is a major health care issue, and the incidence of HF is only expected to grow further. Due to the frequent hospitalizations, HF places a major burden on the available hospital and healthcare resources. In the future, HF care should not only be organized solely at the clinical ward and outpatient clinics, but remote monitoring strategies are urgently needed to guide, monitor, and treat chronic HF patients remotely from their homes as well. The intuitiveness and relatively low costs of non-invasive remote monitoring tools make them an appealing and emerging concept for developing new medical apps and devices. The recent COVID-19 pandemic and the associated transition of patient care outside the hospital will boost the development of remote monitoring tools, and many strategies will be reinvented with modern tools. However, it is important to look carefully at the inconsistencies that have been reported in non-invasive remote monitoring effectiveness. With this review, we provide an up-to-date overview of the available evidence on non-invasive remote monitoring in chronic HF patients and provide future perspectives that may significantly benefit the broader group of HF patients.



2014 ◽  
Vol 172 (3) ◽  
pp. 606-607 ◽  
Author(s):  
Riet Dierckx ◽  
Richard Houben ◽  
Marc Goethals ◽  
Sofie Verstreken ◽  
Jozef Bartunek ◽  
...  


2021 ◽  
Vol 7 ◽  
Author(s):  
Arvind Singhal ◽  
Martin R Cowie

Digital health encompasses the use of information and communications technology and the use of advanced computing sciences in healthcare. This review covers the application of digital health in heart failure patients, focusing on teleconsultation, remote monitoring and apps and wearables, looking at how these technologies can be used to support care and improve outcomes. Interest in and use of these technologies, particularly teleconsultation, have been accelerated by the coronavirus disease 2019 pandemic. Remote monitoring of heart failure patients, to identify those patients at high risk of hospitalisation and to support clinical stability, has been studied with mixed results. Remote monitoring of pulmonary artery pressure has a consistent effect on reducing hospitalisation rates for patients with moderately severe symptoms and multiparameter monitoring shows promise for the future. Wearable devices and apps are increasingly used by patients for health and lifestyle support. Some wearable technologies have shown promise in AF detection, and others may be useful in supporting self-care and guiding prognosis, but more evidence is required to guide their optimal use. Support for patients and clinicians wishing to use these technologies is important, along with consideration of data validity and privacy and appropriate recording of decision-making.



Circulation ◽  
2020 ◽  
Vol 142 (Suppl_3) ◽  
Author(s):  
Fredrick M Ogugua ◽  
Abdulrahman Gamam ◽  
Basilio Addo ◽  
Kofi Osei

Introduction: Remote monitoring (RM) using implantable cardiac defibrillators (ICD) is a rapidly emerging alternative modality in heart failure management. Studies involving US cohorts have shown promising results with RM. We aim to perform a meta-analysis assessing the clinical outcomes of RM versus conventional follow-up among heart failure (HF) patients with an ICD in a European cohort. Methods: Electronic database and reference list searches were conducted to identify European studies assessing patient outcomes when managed with RM using ICD versus conventional follow up. After a review of abstracts and selected full-text articles, we identified four randomized trials (RCT) for inclusion. Quality was assessed using the Cochrane Risk of Bias Tool. The primary outcome was the incidence of HF hospitalization and the secondary outcome was all-cause mortality during the follow-up period. A random-effects model was used. All analysis was performed using Cochrane Revman version 5.3. Results: Four RCT’s were included, with a total of 4504 participants. Mean follow-up time was 22 months. Rate of HF hospitalization with RM was 678 versus 680 with conventional management (RR: 0.98, 95% CI: 0.88 to 1.10, p = 0.75). All-cause mortality with RM was 252 versus 284 with conventional management (RR: 0.88, 95% CI: 0.75 to 1.03, p =0.11). Conclusions: Our study found that in a European cohort, there was no difference in the incidence of HF hospitalization or all-cause mortality among patients managed with RM using ICD and those managed with conventional care. Further research is required to assess the feasibility and generalizability of HF management using ICD’s in different patient populations.



2020 ◽  
pp. 1-5
Author(s):  
Emmanuel ANDRES ◽  
Emmanuel ANDRES ◽  
Samy Talha ◽  
Abrar-Ahmad Zulfiqar ◽  
Noel Lorenzo Villalba ◽  
...  

In recent years, several technological innovations have become part of the daily lives of patients suffered from chronic diseases. It is the case for chronic heart failure with non-invasive sensors, telemedicine, and artificial intelligence. A review of the literature dedicated to these technologies and tools supports the efficacy of these latter. Mainly, these technologies have shown a beneficial effect on chronic heart failure management with an improvement of: patient ownership of the disease; patient adherence to therapeutic and hygiene–dietary measures; the management of co-morbidities (hypertension, weight, dyslipidemia); and at least, good patient receptivity and accountability. Especially, the emergence of these technologies in the daily lives of these patients suffered from chronic disease, as chronic heart failure, has led to an improvement of the quality of life for patients. Nevertheless, the magnitude of its effects remains to date debatable or to be consolidated, especially with the variation in patients' characteristics, methods of experimentation, and in terms of medical and economic objectives.



2013 ◽  
Vol 19 (6) ◽  
pp. 326-337 ◽  
Author(s):  
Aaron Conway ◽  
Sally C Inglis ◽  
Anne M Chang ◽  
Margaret Horton-Breshears ◽  
John GF Cleland ◽  
...  


2021 ◽  
Vol 32 ◽  
pp. 100724
Author(s):  
Enrico Bertagnin ◽  
Antonio Greco ◽  
Giuseppe Bottaro ◽  
Paolo Zappulla ◽  
Imma Romanazzi ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document